Cargando…
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
Mutations in leucine-rich repeat kinase 2 (LRRK2) are one of the most common causes of familial Parkinson’s disease (PD). The most common mutations in the LRRK2 gene induce elevated kinase activity of the LRRK2 protein. Recent studies have also suggested that LRRK2 kinase activity may be elevated in...
Autores principales: | Henderson, Michael X., Sengupta, Medha, McGeary, Ian, Zhang, Bin, Olufemi, Modupe F., Brown, Hannah, Trojanowski, John Q., Lee, Virginia M. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391792/ https://www.ncbi.nlm.nih.gov/pubmed/30808409 http://dx.doi.org/10.1186/s40478-019-0679-5 |
Ejemplares similares
-
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
por: Henderson, Michael X., et al.
Publicado: (2019) -
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
por: Henderson, Michael X., et al.
Publicado: (2018) -
Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies
por: Peng, Chao, et al.
Publicado: (2018) -
LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons
por: Henderson, Michael X., et al.
Publicado: (2021) -
α-Synuclein pathology spread through the brain connectome is modulated by selective vulnerability and predicted by network analysis
por: Henderson, Michael X., et al.
Publicado: (2019)